Cytokines in Liver Injury and Repair

Inbunden, Engelska, 2002

AvA. M. Gressner,P. C. Heinrich,A.M. Gressner,P.C. Heinrich,S. Matern

2 219 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

This book, the proceedings of Falk Symposium No. 125 on 'Cytokines in Liver Injury and Repair' (Progress in Gastroenterology and Hepatology Part II), held in Hannover, Germany, on September 30 - October 1, 2001, provides an update of our current knowledge on the role of cytokines in various human and experimental liver diseases and on their present and prospective use in therapeutic trials. The book contains chapters by most well-known experts in the field who have contributed significantly to our present knowledge on cytokines in liver injury and repair.

Produktinformation

Utgivningsdatum2002-06-30
Mått155 x 235 x 29 mm
Vikt837 g
FormatInbunden
SpråkEngelska
SerieFalk Symposium
Antal sidor400
Upplaga2002
FörlagKluwer Academic Publishers
ISBN9780792387756

Tillhör följande kategorier

Hepatologi inom Medicin
Gastroenterologi inom Medicin

Preface. Section I: Cytokine-Induced Cell Death. 1. Endogenous modulators of receptor-mediated hepatic cell death; H. Hentze, et al. 2. Modulation of CD 95 (APO-1/Fas) induced hepatocyte death by NO; PR. Galle, et al. 3. TGF-beta-induced liver cell apoptosis; R. Schulte-Hermann, et al. Section II: Regulation of Normal and Malignant Cell Growth by Cytokines. 4. Proliferative and apoptotic effects of tumour necrosis factor in the liver and cells in culture; N. Fausto, J. Campbell. 5. The role of insulin-like growth factor-II in hepatocarcinogenesis; P. Lund, et al. 6. Transforming growth factor-beta and cancer; M. Reiss. 7. Cytokines and hepatitis C virus replication; D. Moradpour, et al. Section III: Cytokine Signals in Fibrogenesis. 8. Role of DDR2 receptor in the activation of hepatic stellate cells; E. Olaso, et al. 9. PDGF signalling in activated stellate cells; M. Pinzani. 10. Escape of activated hepatic stellate cells from TGF-beta control; S. Dooley, et al. 11. Chemokines in the modulation of liver inflammation; F. Marra, et al. Section IV: Modulation of Fibrogenic Cytokine Response. 12. Identification of fibrogenic genes in a polygenic mouse model of liver fibrosis; F. Lammert, et al. 13. Cytokine transgenic models of fibrogenesis; S. Kanzler. 14. The fibrogenic mediators of TGF-beta and TNF-alpha as surviving factors for activated hepatic stellate cells; G. Ramadori, B. Saile. 15. Resolution of fibrosis by apoptosis of myofibroblasts; F. Murphy, J.P. Iredale. Section V: Cytokines in the Cause and Consequence of Cholestatis. 16. Regulation of hepatic organic anion transporters by cytokines; A. Geier, et al. 17. Reaction of cholangiocytes to inflammatory injury; C. Spirli, et al. 18. Bid antisense oligodeoxynucleotides as therapy for cholestatic liver injury; H. Higuchi, G.J. Gores. Section VI: Polymorphisms of Cytokines and Signalling. 19. Regulation of interleukin-6-type cytokine signaling; P.C. Heinrich, et al. 20. IL6-dependent signal transduction and its relevance in animal models; K.L. Streetz, et al. 21. Predictive value of cytokine polymorphisms for liver disease; P.T. Donaldson, C.P. Day. Section VII: Therapeutic Cytokines and Modulators. 22. PPARgamma and fibrogenesis; T. Miyahara, et al. 23. Cytokine modulation in the therapy of hepatic immunopathology and fibrosis; S.M. Wahl, et al. 24. Matrix binding motifs and peptide mimetics as modulators of wound healing and fibrogenesis; D. Schuppan, et al. 25. Endothelin and liver injury -- therapeutic antagonism of the endothelin system; D.C. Rockey. 26. Transforming growth factor ss in the treatment of autoimmune disease; A.W. Lohse. Section VIII: Cytokine-Assisted Gene Therapies. 27. The feasibility of antifibrotic gene therapy; T.J. Davern, D.M. Bissell. 28. Experimental approaches to antifibrotic strategies using gene transfer; R. Weiskirchen, et al. 29. Cytokine-assisted gene therapy: Anti-TGF-ss intervention using mutated forms of TGF-ss receptor; H. Ueno, et al. 30. Cytokine-based gene therapy of hepatocellular carcinoma (HCC); C. Qian, et al. Index.

Mer från samma serie

Acute and Chronic Liver Diseases

R. Schmid, L. Bianchi, H.E. Blum, W. Gerok, K.P. Maier, G.A. Stalder

Inbunden, 1996

2 949 kr

Molecular Diagnosis and Gene Therapy

H.E. Blum, C.H. Wu, G.Y. Wu

Inbunden, 1996

2 949 kr

Pregnancy, Sex Hormones and the Liver

H. B. Reyes, U. Leuschner, H.B. Reyes, U. Leuschner, I.M. Arias

Inbunden, 1996

2 949 kr

Glucocorticoid Therapy in Chronic Inflammatory Bowel Disease

H.W. Mollmann, B. May

Inbunden, 1996

2 219 kr

Cholestatic Liver Diseases in Children and Adults

C.E. Broelsch, M. Burdelski, X. Rogiers

Inbunden, 1997

1 479 kr

Zinc and Diseases of the Digestive Tract

J.D. Kruse-Jarres, J. Schölmerich

Inbunden, 1997

2 219 kr

Bile Acids and Hepatobiliary Diseases - Basic Research and Clinical Application

G. Paumgartner, A. Stiehl, W. Gerok

Inbunden, 1997

2 949 kr

Gut as a Model in Cell and Molecular Biology

F. Halter, D. Winton, N.A. Wright

Inbunden, 1997

3 719 kr

Constipation and Ano-Rectal Insufficiency

K. Ewe, V.F. Eckardt, P. Enck

Inbunden, 1997

2 949 kr

Autoimmune Liver Disease

P.A. Berg, A.W. Lohse, G. Tiegs, A. Wendel

Inbunden, 1997

2 219 kr

Du kanske också är intresserad av

Clinical Research in Gastroenterology 1

S. Matern

Häftad, 2011

749 kr

Hepatobiliary Transport: From Bench to Bedside

S. Matern, J.L. Boyer, D. Keppler, P.J. Meier-Abt

Inbunden, 2001

2 219 kr

Hepatic Metabolism and Disposition of Endo- and Xenobiotics

Karl-Walter Bock, W. Gerok, S. Matern

Inbunden, 1991

2 949 kr

Clinical Research in Gastroenterology 2

S. Matern

Inbunden, 1989

1 479 kr

Clinical Research in Gastroenterology 2

S. Matern

Häftad, 2011

1 479 kr

Nyhet

Del 11

Medusa

Lars Kepler

Inbunden, 2026

289 kr319 kr

Ruth Kvarnström-Jones - Systrarna på Sophiahemmet, Inbunden

Nyhet

Del 3

Systrarna på Sophiahemmet

Ruth Kvarnström-Jones

Inbunden, 2026

299 kr329 kr

Nyhet

Del 1

Blackout

Sofie Sarenbrant

Inbunden, 2026

269 kr319 kr

Nyhet

Del 4

Sot

Sara Strömberg

Pocket, 2026

79 kr129 kr

Del 1

Sly

Sara Strömberg

Pocket, 2022

79 kr129 kr

Del i serien Falk Symposium

Cytokines in Liver Injury and Repair

Inbunden, Engelska, 2002

AvA. M. Gressner,P. C. Heinrich,A.M. Gressner,P.C. Heinrich,S. Matern

2 219 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

Produktinformation

Utgivningsdatum2002-06-30
Mått155 x 235 x 29 mm
Vikt837 g
FormatInbunden
SpråkEngelska
SerieFalk Symposium
Antal sidor400
Upplaga2002
FörlagKluwer Academic Publishers
ISBN9780792387756

Tillhör följande kategorier

Hepatologi inom Medicin
Gastroenterologi inom Medicin

Preface. Section I: Cytokine-Induced Cell Death. 1. Endogenous modulators of receptor-mediated hepatic cell death; H. Hentze, et al. 2. Modulation of CD 95 (APO-1/Fas) induced hepatocyte death by NO; PR. Galle, et al. 3. TGF-beta-induced liver cell apoptosis; R. Schulte-Hermann, et al. Section II: Regulation of Normal and Malignant Cell Growth by Cytokines. 4. Proliferative and apoptotic effects of tumour necrosis factor in the liver and cells in culture; N. Fausto, J. Campbell. 5. The role of insulin-like growth factor-II in hepatocarcinogenesis; P. Lund, et al. 6. Transforming growth factor-beta and cancer; M. Reiss. 7. Cytokines and hepatitis C virus replication; D. Moradpour, et al. Section III: Cytokine Signals in Fibrogenesis. 8. Role of DDR2 receptor in the activation of hepatic stellate cells; E. Olaso, et al. 9. PDGF signalling in activated stellate cells; M. Pinzani. 10. Escape of activated hepatic stellate cells from TGF-beta control; S. Dooley, et al. 11. Chemokines in the modulation of liver inflammation; F. Marra, et al. Section IV: Modulation of Fibrogenic Cytokine Response. 12. Identification of fibrogenic genes in a polygenic mouse model of liver fibrosis; F. Lammert, et al. 13. Cytokine transgenic models of fibrogenesis; S. Kanzler. 14. The fibrogenic mediators of TGF-beta and TNF-alpha as surviving factors for activated hepatic stellate cells; G. Ramadori, B. Saile. 15. Resolution of fibrosis by apoptosis of myofibroblasts; F. Murphy, J.P. Iredale. Section V: Cytokines in the Cause and Consequence of Cholestatis. 16. Regulation of hepatic organic anion transporters by cytokines; A. Geier, et al. 17. Reaction of cholangiocytes to inflammatory injury; C. Spirli, et al. 18. Bid antisense oligodeoxynucleotides as therapy for cholestatic liver injury; H. Higuchi, G.J. Gores. Section VI: Polymorphisms of Cytokines and Signalling. 19. Regulation of interleukin-6-type cytokine signaling; P.C. Heinrich, et al. 20. IL6-dependent signal transduction and its relevance in animal models; K.L. Streetz, et al. 21. Predictive value of cytokine polymorphisms for liver disease; P.T. Donaldson, C.P. Day. Section VII: Therapeutic Cytokines and Modulators. 22. PPARgamma and fibrogenesis; T. Miyahara, et al. 23. Cytokine modulation in the therapy of hepatic immunopathology and fibrosis; S.M. Wahl, et al. 24. Matrix binding motifs and peptide mimetics as modulators of wound healing and fibrogenesis; D. Schuppan, et al. 25. Endothelin and liver injury -- therapeutic antagonism of the endothelin system; D.C. Rockey. 26. Transforming growth factor ss in the treatment of autoimmune disease; A.W. Lohse. Section VIII: Cytokine-Assisted Gene Therapies. 27. The feasibility of antifibrotic gene therapy; T.J. Davern, D.M. Bissell. 28. Experimental approaches to antifibrotic strategies using gene transfer; R. Weiskirchen, et al. 29. Cytokine-assisted gene therapy: Anti-TGF-ss intervention using mutated forms of TGF-ss receptor; H. Ueno, et al. 30. Cytokine-based gene therapy of hepatocellular carcinoma (HCC); C. Qian, et al. Index.